$MRVL

Koopmans Chris sold $2.1M of MRVL (indirect holdings)

Koopmans Chris (President and COO) sold 10,000 indirectly-held shares of Marvell Technology, Inc. (MRVL) at $205.87 ($2.06M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Koopmans Chris
Published Jun 2, 2026, 12:32 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 1:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MRVL
Neutral
medium confidence
Mentioned
$MRVL
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRVLNeutralLow
01

Why it matters

The main trading relevance is potential short-term sentiment impact from insider selling; however, 10b5-1 plans are designed to reduce timing-based information content.

02

Market read

A routine 10b5-1 insider sale; any effect is likely limited to near-term sentiment rather than fundamentals.

03

What to watch

The filing does not indicate why the sale occurred (taxes/diversification are common), and it provides no new operational or financial information about Marvell.

Relevance 7/10Novelty 3/10Timing: SEC Form 4 filed/posted after-hours on 2026-06-01 (for June 1 sale).

Background

This is an SEC Form 4 insider transaction disclosure: Koopmans (President and COO) sold 10,000 MRVL shares at ~$205.87 on 2026-06-01, with an indirect ownership form and a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$MRVLNeutralMedium confidence
Context

Marvell’s President/COO Chris Koopmans sold $2.06M of MRVL shares via an open-market transaction under a 10b5-1 plan on June 1.

Expected impact

Limited, mostly sentiment-driven; any impact should fade unless accompanied by other negative company news.

Evidence & confidence

The filing is a routine insider transaction with a pre-arranged 10b5-1 plan, reducing the likelihood of new negative information.

Market effects

No direct sector read-through; this is company-specific insider activity.

None.

None.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, the market may overreact; price action could be muted or even stabilize quickly.

Key entities

  • Marvell Technology, Inc.

    Subject of the insider transaction disclosure; officer sale under 10b5-1.

  • Chris Koopmans

    President and COO who sold MRVL shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TSMMedAI 8/10

Marvell Technology and Taiwan Semiconductor are No-Brainer Picks: They Have What Wins in a Gold Rush

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, positioning them as key players in AI infrastructure. TSM's Q2 2026 revenue rose 36% YoY to $40.2B, with advanced nodes driving 77% of wafer revenue. MRVL's Q2 2027 revenue increased 36.5% YoY to $2.74B, with data center revenue up 46% YoY. Both companies are seen as essential for AI development, with TSM benefiting from broad industry demand and MRVL tied to hyperscaler custom silicon cycles.

$TSMHighAI 8/10

Marvell Technology and Taiwan Semiconductor are No

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, with TSM posting $40.20B revenue and $4.31 EPS, while MRVL saw 36.5% revenue growth and 46% data center revenue increase. TSM's advanced nodes drove 77% of wafer revenue, and MRVL's custom silicon business is expected to double by fiscal 2028. Both companies are key players in AI infrastructure.

$MRVLMedAI 8/10

Marvell stock is down 36% from recent all-time highs; can it get its mojo back?

Marvell Technology (MRVL) shares have fallen 36% from their all-time high, trading at $213.33 in pre-market. Despite a 226% gain over the past year, the stock dropped 7.9% post-earnings due to margin compression concerns and deferred long-term guidance. The company reported Q2 revenue of $2.74B (+37% YoY) and raised FY2027 guidance to ~$12B. Analysts remain bullish, with targets up to $400, but bears cite margin pressures and potential AI capex slowdowns. Investor Day in October is a key catalys

$MRVLHighAI 8/10

MRVL Stock Heads For Worst Day In A Month After Q2: Analyst Sees Blue-Chip Customers, Broad Portfolio As Healthy Growth Signals

Marvell Technology (MRVL) shares fell 8.2% premarket after Q2 results, despite a new AI chip deal with Google. Analysts highlighted its blue-chip customers and diversified portfolio as growth drivers. Morningstar raised its price target to $300, while Goldman Sachs maintained a 'Neutral' rating with a $195 target. MRVL reported $2.74B in sales, up 37%, and raised fiscal 2028 sales guidance to $18B.